
Overview
I am a Comprehensive Ophthalmologist who specializes in patients with cataracts and cataract surgery related problems. When it comes to treating patients, I like to have a clear understanding of their problems and expectations so that I can explain what I can reasonably do for them. Seeing the satisfaction of a happy patient after successful cataract surgery is my favorite part of my job. I have always enjoyed working and interacting with people and feeling like I can improve their lives. I enjoy being in a scientific field and the optics, anatomy and skills required to become an ophthalmologist drew my interest after my grandfather underwent cataract surgery while I was a teenager. Outside of work I enjoy running, cycling, triathlons and ballroom dancing.
Dr. Vann is highly rated in 1 condition, according to our data. His top areas of expertise are Cataract, Pigment-Dispersion Syndrome, Glaucoma, Ocular Hypertension (OHT), and Cataract Removal.
His clinical research consists of co-authoring 12 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- POS
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
5601 Arringdon Park Dr, Morrisville, NC 27560
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
University Of North Carolina At Chapel Hill
Alessandro Iannaccone is an Ophthalmologist in Chapel Hill, North Carolina. Dr. Iannaccone is highly rated in 30 conditions, according to our data. His top areas of expertise are Retinitis Pigmentosa, Retinopathy Pigmentary Mental Retardation, X-Linked Retinitis Pigmentosa (XLRP), and Usher Syndrome Type 2A. Dr. Iannaccone is currently accepting new patients.
Duke Health Integrated Practice Inc
Michalis Georgiou is an Ophthalmologist in Durham, North Carolina. Dr. Georgiou has been practicing medicine for over 9 years is highly rated in 16 conditions, according to our data. His top areas of expertise are Color Blindness, Retinopathy Pigmentary Mental Retardation, Cone-Rod Dystrophy, Vitrectomy, and Trabeculectomy. Dr. Georgiou is currently accepting new patients.
Cynthia Toth is an Ophthalmologist in Durham, North Carolina. Dr. Toth is highly rated in 14 conditions, according to our data. Her top areas of expertise are Retinopathy of Prematurity, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Vitrectomy, and Trabeculectomy. Dr. Toth is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- CataractDr. Vann isDistinguished. Learn about Cataract.
- Experienced
- Age-Related Macular Degeneration (ARMD)
- AstigmatismDr. Vann isExperienced. Learn about Astigmatism.
- Cataract RemovalDr. Vann isExperienced. Learn about Cataract Removal.
- Corneal Dystrophy and Perceptive Deafness
- GlaucomaDr. Vann isExperienced. Learn about Glaucoma.
- Late-Onset Retinal DegenerationDr. Vann isExperienced. Learn about Late-Onset Retinal Degeneration.
